LabPON Adopts Proscia’s Concentriq to Meet Demand for Cancer Diagnostic Services

By Author Proscia | January 12, 2021

Laboratorium Pathologie Oost-Nederland (LabPON), Hengelo, Netherlands, will deploy Philadelphia-based Proscia’s Concentriq platform. In transitioning to Concentriq, LabPON gains added flexibility to scale its routine digital pathology operations as the total number of worldwide cancer cases continues to rise. This includes establishing the software infrastructure for later implementing computational applications leveraging artificial intelligence to further improve diagnostic quality and efficiency.

Our website uses cookies. By using this site, you agree to its use of cookies.